SSI Diagnostica Group is promoting Mie Nete Petersen to Vice President of Global Strategy & Corporate Development. She has undertaken a crucial role in developing our strategy and long-term growth ambition. Mie has extensive experience from large companies like Novo Nordisk and Coloplast working with strategy, commercial development and marketing before joining SSI Diagnostica in February 2022.

“To accelerate and deliver on our ambitious growth agenda, I’m happy to announce the promotion of Mie Petersen to Vice President. She has been a member of the Global Leadership Team since January 2023 and since then she has been leading the Global Strategy and Corporate Development function. She is a valuable resource to the Leadership, Board and organization. We are lucky to have such talents at SSI Diagnostica Group, and Mie will continue to be an immensely important resource to our growth and success,” says Christina Lindved, Group CEO.

SSI Diagnostica Group’s main goal is to serve the clinical diagnostic market in the effort of preventing, monitoring, and diagnosing people, ultimately supporting better treatment outcomes for patients globally.